Regeneron Pharmaceuticals, one of the fastest-growing companies in the global biotechnology industry, have announced further expansion of its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus.

An additional 300 jobs will bring employment at the company to 800 people.

Regeneron are investing €84.9 million ($100 million) at the site, bringing the total investment to €636 million ($750 million).

The project is supported by the government through IDA Ireland.

The additional €84.9 million investment will support the construction of a number of manufacturing suites to increase drug substance production capacity and enable the company to meet demand for its life-transforming medicines for patients with serious diseases.

Dan Van Plew, Executive Vice President and General Manager of Industrial Operations and Product Supply (IOPS) at Regeneron, said:

“Gut feel is a large portion of any site selection. When we picked Limerick years ago, we simply felt good about the community, universities and people. A few years and a lot of experience later, I can now confidently say I know Limerick is a place where you can build and thrive as a biotech.

“We are proud of what has happened here and the vast majority of this work has been completed by people who come from Munster. These folks built, validated and began production in a way I’d put up against any other team on the planet.

“We feel at home here and the way we have been welcomed has made our ongoing growth and investment in Limerick rewarding on the most personal levels.”